Researchers Submit Patent Application, "Compositions And Methods For Optimized Kras Peptide Vaccines", for Approval (USPTO 20240131133).

A patent application titled "Compositions And Methods For Optimized Kras Peptide Vaccines" has been submitted. The inventors are working on developing peptide vaccines that can train the immune system to recognize and respond to cancerous cells or pathogens. The invention involves using nucleic acid sequences to encode specific amino acid sequences, which can be used to prevent or treat cancer. The composition may include multiple peptides derived from mutated proteins, such as KRAS. The patent application provides detailed claims and additional information for those interested in further research on this topic. [Extracted from the article]